论文部分内容阅读
两项新的研究显示血营紧张素受体Ⅱ拮抗剂厄贝沙坦减缓Ⅱ型糖尿病患者的肾病进程有效,并认为该药的这种对肾脏的保护作用与其降血压作用无关。
Two new studies have shown that the angiotensin II receptor antagonist irbesartan is effective in slowing the progression of nephropathy in patients with type 2 diabetes and that its protective effect on the kidneys is independent of its hypotensive effect.